Using FAPI PET-CT to diagnose endometriosis
Official title: Use of Fibroblast Activation Protein Inhibitor (FAPI) PET-CT Before Surgery in Patient with Endometriosis
Run by Ziv Hospital · NCT06792318 · Data updated 2026-11-12
This study is testing a new imaging method called FAPI PET-CT to see if it can help diagnose endometriosis in patients before they have surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Ziv Hospital Government |
| Drugs / interventions | Radiation |
| Locations | 1 site (Safed) |
| Status | Recruiting |
| Started | March 2025 |
| Main results expected | January 2027 |
| Study ends | June 2027 |
| Registry record updated | January 24, 2025 |
| Trial ID | NCT06792318 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are females aged 18-45 with clinical suspicion of endometriosis who are scheduled for laparoscopic surgery.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have a history of pelvic radiation therapy or active malignancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility of FAPI PET-CT imaging for diagnosing endometriosis in patients scheduled for surgery. Participants will receive a single injection of FAPI and undergo multiple imaging sessions to assess the presence of endometriotic lesions. The results from the imaging will be compared with surgical findings and pathology to determine accuracy. The study aims to provide a non-invasive method for better pre-operative planning and lesion mapping.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and less invasive diagnosis of endometriosis, improving patient outcomes.
How similar studies have gone: While the use of FAPI PET-CT is a novel approach in this context, similar imaging techniques have shown promise in other diagnostic applications.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female participants aged 18-45 years * Clinical suspicion of endometriosis based on symptoms * Scheduled for diagnostic/therapeutic laparoscopic surgery * Ability to understand and provide written informed consent * Completed and signed Radiation Exposure Documentation Form Exclusion Criteria: * Pregnant women or women who are breastfeeding * History of pelvic radiation therapy * Known active malignancy * Exposure to ionizing radiation for medical purposes within 12 months prior to enrollment
Where it's running
-
Ziv Medical Center
Safed, Israel Recruiting
Study contacts
- Study coordinator: Israel Sandler, MD
- Email: israels@ziv.gov.il
- Phone: +972-527-362280
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.